Status:
COMPLETED
Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Conditions:
Adenocarcinoma, Bronchiolo-Alveolar
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To evaluate among patients with untreated advanced ADC-CBA, impact on the disease control rate after 4 months treatment of an early therapeutic permutation with the first month in the absence of stabi...
Eligibility Criteria
Inclusion
- CBA histologically proven (or cytologically with pneumonic presentation) PS \< 3 signed and written informed consent
Exclusion
- visible tumoral lesion in bronchial fibroscopy
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT00384826
Start Date
September 1 2006
End Date
February 1 2014
Last Update
February 16 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier - Pneumologie
Belfort, France, 90016
2
APHP - CHU Avicenne - Oncologie Medicale
Bobigny, France, 93000
3
Centre F. Baclesse
Caen, France, 14000
4
CHU - Pneumologie
Caen, France, 14000